J. Hyest and G. Cabanel, Conditions of life in french jails, report of inquiry commission in the french Senat n4 49, 1999.

P. Bouhnik, E. Jacob, I. Maillard, and S. Touzé, The amplification of risks among drugs users: prison-polyconsumption-maintenance treatment, RESSCOM survey, 1999.

M. Mouquet, French direction of research, studies, evaluation and statistics: health of inmates who arrived in jail in 2003, 2005.

B. Falissard, J. Y. Loze, I. Gasquet, A. Duburc, C. De-beaurepaire et al., Prevalence of mental disorders in French prisons for men, BMC Psychiatry, vol.6, p.33, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00097911

F. Sahajian, P. Lamothe, and J. Fabry,

, Sante Publique, vol.18, issue.2, pp.223-257, 2006.

M. Lukasiewicz, B. Falissard, L. Michel, X. Neveu, M. Reynaud et al., Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study, Subst Abuse Treat Prev Policy, vol.2, p.17204156, 2007.

J. N. Marzo, M. Rotily, F. Meroueh, M. Varastet, C. Hunault et al., Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06), Addiction, vol.104, issue.7, p.19426291, 2009.

F. Sahajian, P. Lamothe, J. Fabry, and P. Vanhems, Consumption of psychoactive substances among 535 women entering a Lyon prison (France) between, Rev Epidemiol Sante Publique, vol.60, issue.5, pp.371-81, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02278577

O. Sannier, F. Verfaillie, and D. Lavielle, Risk reduction and drug use in detention: study about the detainees of Liancourt Penitentiary, Presse Med, vol.41, issue.7-8, pp.375-85, 2012.

P. Rossard, S. Riuné--lacabe, P. Cousin, C. Denis, and M. Auriacombe, Substance use and risk behavior during incarceration, survey in a french jail, Le courrier des addictions, vol.14, issue.2, pp.28-30

F. Sahajian, A. Berger-vergiat, and E. Pot, Use of psychoactive substances in prison: Results of a study in the Lyon-Corbas prison, France. Rev Epidemiol Sante Publique, vol.65, issue.5, pp.361-368, 2017.

S. Fazel, P. Bains, and H. Doll, Substance abuse and dependence in prisoners: a systematic review, Addiction, vol.101, issue.2, pp.181-91, 2006.

L. Michel, Drug use in prisons: strategies for harm reduction (ANRS-PRIDE Program), Cien Saude Colet, vol.21, issue.7, pp.2081-2089, 2016.

L. Michel, P. Trouiller, A. Chollet, M. Molinier, L. Duchesne et al., Self-reported injection practices among people who use drugs in French prisons: Public health implications (ANRS-Coquelicot survey 2011-2013), Drug Alcohol Rev, vol.37, issue.1, pp.268-76, 2018.

C. Semaille, L. Strat, Y. Chiron, E. Chemlal, K. Valantin et al., Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy, Euro Surveill, vol.18, issue.28, 2013.

. Inserm, Psychotropic drugs: consumptions and pharmacodependences, 2012.

, French Ministry of Health and Social Protection FMoJ. Methodological Guide of Health Care on inmates, 2004.

L. Michel, M. Jauffret-roustide, J. Blanche, O. Maguet, C. Calderon et al., Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy. BMC Public Health, vol.11, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00605495

M. Jauffret-roustide, J. Emmanuelli, M. Quaglia, F. Barin, P. Arduin et al., Impact of a harmreduction policy on HIV and hepatitis C virus transmission among drug users: recent French data-the ANRS-Coquelicot Study, Subst Use Misuse, vol.41, pp.1603-1624, 2006.

M. Jauffret-roustide, J. Emmanuelli, and J. C. Desenclos, Limited impact of the harm-reduction policy on HCV among drug-users. The ANRS-Coquelicot survey example

, Rev Epidemiol Sante Publique, vol.54, pp.1-53, 2006.

. Inserm and . French, Expertise Inserm. Reduction of infectious risks among drugs users, pp.309-349

, French Ministry of Health and Social Protection FMoJ. Guide of opioid maintenance treatment in prison

E. Jouanjus, V. Gibaja, J. P. Kahn, F. Haramburu, and A. Daveluy, Signal identification in addictovigilance: the functioning of the French system, Therapie, vol.70, issue.2, pp.113-144, 2015.

J. Micallef and M. Mallaret, Twenty-five years of the French Addictovigilance Network (FAN), Therapie, vol.71, issue.4, pp.375-383, 2016.

S. Nordmann, E. Frauger, V. Pauly, F. Rouby, M. Mallaret et al., Post-marketing surveillance systems for psychoactive prescription drug abuse, Therapie, vol.66, issue.3, pp.263-72, 2011.

V. Pauly, E. Frauger, F. Rouby, S. Sirere, S. Monier et al., Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program, Encephale, vol.36, issue.2, pp.122-153, 2010.

S. T. Lanza and B. L. Rhoades, Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment, Prev Sci, vol.14, issue.2, p.21318625, 2013.

L. M. Collins and S. T. Lanza, Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences

, Observatoire français des drogues et des toxicomanies OFDT. [Drugs, Key figures, 2017.

F. Ministry and . Justice, Prevention of recidivism and individualization of sentences, key figures, 2014.

S. E. Wakeman, Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy, AMA J Ethics, vol.19, issue.9, pp.922-952, 2017.

, Observatoire français des drogues et des toxicomanies OFDT. [Social characteristics, consumption and risks among drug users attending needle exchange programs in France, 1999.

T. Al-rousan, L. Rubenstein, B. Sieleni, H. Deol, and R. B. Wallace, Inside the nation's largest mental health institution: a prevalence study in a state prison system, BMC Public Health, vol.17, issue.1, p.342, 2017.

F. G. Kouyoumdjian, L. M. Calzavara, L. Kiefer, C. Main, and S. J. Bondy, Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada, Can J Public Health, vol.105, issue.3, pp.198-202, 2014.

A. Wiley and S. O'neill, Tobacco and Other Drugs Nursing within a Correctional Setting, Aust Nurs Midwifery J, vol.24, issue.6, p.39, 2016.

S. Fazel, T. Ramesh, and K. Hawton, Suicide in prisons: an international study of prevalence and contributory factors, Lancet Psychiatry, vol.4, issue.12, pp.946-52, 2017.

A. Albertie, C. Bourey, R. Stephenson, S. Bautista-arredondo, and . Connectivity, prison environment and mental health among first-time male inmates in Mexico City, Glob Public Health, vol.12, issue.2, pp.170-84, 2017.

F. Caravaca-sanchez, F. Romero, M. , and L. A. ,

, Gac Sanit, vol.29, issue.5, pp.358-63, 2015.

L. S. Rubenstein, J. J. Amon, M. Mclemore, P. Eba, K. Dolan et al., HIV, prisoners, and human rights, Lancet, vol.388, issue.16, pp.30663-30671, 2016.

N. M. Wright, C. N. Tompkins, and T. M. Farragher, Injecting drug use in prison: prevalence and implications for needle exchange policy, Int J Prison Health, vol.11, issue.1, pp.17-29, 2015.

R. Jurgens, A. Ball, and A. Verster, Interventions to reduce HIV transmission related to injecting drug use in prison, Lancet Infect Dis, vol.9, issue.1, pp.57-66, 2009.

D. Shewan, M. Gemmell, and J. B. Davies, Behavioural change amongst drug injectors in Scottish prisons, Soc Sci Med, vol.39, issue.11, pp.1585-1591, 1994.

L. H. Dewa, L. Hassan, J. J. Shaw, and J. Senior, Insomnia management in prisons in England and Wales: a mixed-methods study, J Sleep Res, vol.26, issue.3, pp.322-331, 2017.

E. Plugge, P. Yudkin, and N. Douglas, Changes in women's use of illicit drugs following imprisonment, Addict Abingdon Engl, vol.104, issue.2, pp.215-237, 2009.